3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
70
Rectal Neoplasms
28
Colonic Neoplasms
28
Carcinoma, Hepatocellular
26
Neoplasm Metastasis
15
Stomach Neoplasms
12
Pancreatic Neoplasms
7
Cholangiocarcinoma
6
Adenocarcinoma Of Esophagus
6
Esophageal Neoplasms
5
Recurrence
4
Liver Neoplasms
4
Biliary Tract Neoplasms
4
Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Peritoneal Neoplasms
2
Neoplastic Cells, Circulating
2
Gastrointestinal Neoplasms
2
Colorectal Cancer Metastatic
2
Cirrhosis, Familial, with Pulmonary Hypertension
2
Adenocarcinoma
2
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Pathologic Complete Response
1
Pancreatic Adenocarcinoma
1
Operable T2-3N+M0 Rectal Cancer (Stage III)
1
Oligometastatic Gastric Adenocarcinoma
1
Neurotoxicity Syndromes
1
Neuropathy, Painful
1
Neuralgia
1
Interventions
pembrolizumab
4
Trastuzumab
4
Oxaliplatin
4
Fluorouracil
4
Cyclophosphamide
4
Carboplatin
4
Radiotherapy
3
Paclitaxel
3
Endoscopy
3
Docetaxel
3
Cytarabine
3
Chemoradiotherapy
3
Capecitabine
3
toripalimab
2
Tretinoin
2
Surgical Procedures, Operative
2
Standard of Care
2
Observation
2
Neoadjuvant Therapy
2
Metformin
2
Magnetic Resonance Imaging
2
Leucovorin
2
Irinotecan
2
Immunotherapy
2
Immune Checkpoint Inhibitors
2
Epirubicin
2
Drug Therapy
2
Doxorubicin
2
Cisplatin
2
Blood Specimen Collection
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pathologic Complete Response
×
Folfox protocol
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled